Post by
Ingiboy on Mar 23, 2022 3:03pm
Twitter Update
Now that I have time to digest this recent "Update" on March 18th followed 4 days later by a private placement of 8,333,333 shares is a typical move by Replicel. The natives were screaming for some sort of update so let's give them afew meaningless crumbs before we hit them with the dilution.
We were expecting some type of timeline or outright announcement regarding seeking FDA Approval for the Dermal Injector but what did we get: "data pouring in". In October they made an announcement that the testing phase would be performed at the Monasterium lab and would take approx. 3 months. That is long gone but yet they are still testing the device. One might draw the conclusion that the device is far from ready for FDA Approval and this update was merely "kicking the can down the road" which places them in a financial crunch thus yet another private placement.
I try to be positive here but I have long stopped drinking the Kool-aide. By the way what the hell is happening with this Shiseido Arbitration ? It has been 6 months since the Arbitration was announced in Oct. 2021. On Dec. 21st 2021 Replicel tweeted:
"We have now terminated Shiseido's license to RCH-01. In the context of our arbitration, this provides RepliCel with the widest array of remedies including damages, return of license, etc. Nothing prevents the parties from settling this dispute any time."
Well I guess an early settlement is out of the question for Shiseido
Comment by
toniZ1 on Mar 23, 2022 3:45pm
lets see who got those shares, then we know better. the arbitration timeframe was 6-12 months or any time.... I don't see that Shiseido setups a LAB, runs a 2nd study and then drops everything. Guess we will get an outcome within the next 3 months. Any other good news is very welcome, but I dont expect any.
Comment by
hurko5 on Mar 23, 2022 3:55pm
This post has been removed in accordance with Community Policy